Eitan Konstantino, PhD
President & CEO, Co-Founder

Prior to co-founding TMI, Dr. Konstantino was co-founder, president and chief scientist of AngioScore Inc from its inception until 2006. Dr. Konstantino is the primary inventor of the AngioSculpt catheter and the Easy Exchange delivery system. Previously, Dr. Konstantino was the CEO & COO of Advanced Stent Technologies (AST), a bifurcation stent company that was acquired by Boston Scientific in 2004. He co-invented the Petal bifurcation stent that is currently in development at Boston Scientific. Prior to AST, he was Chief Technical Officer of Bypass Ltd, a developer of nitinol anastomotic devices for minimally invasive heart surgery. Dr. Konstantino received his PhD from Technion, Israel's premier engineering school. He currently serves as the co-chairman of the ASTM F04.30.06 Cardiovascular Standards Task Group.

Christopher Haig
Vice President of Marketing, Sales and Business Development

Mr. Haig brings over 20 years of US, European, and Asian experience in mature and early stage healthcare companies. His track record includes numerous successful product launches and pioneering commercialization and market development efforts in various fields such oral contraceptives, angioplasty devices, healthcare information, and radiation oncology. Prior to joining TMI in January of 2009, Mr. Haig was the VP, Marketing and Business Development with Calypso Medical Technologies, a privately held medical device company focused on improving the accuracy of external beam radiation therapy for cancer. Prior to joining Calypso, he spent 15 years in various marketing and business development roles of increasing responsibility with Guidant and Abbott Vascular. Most recently, Mr. Haig was the Director of Global Marketing for Drug Eluting Stents, which included responsibility for products such as Xience V and the next generation workhorse, bifurcation, and bioabsorbable stents. He earned an MBA from the Kenan-Flagler School of Business at the University of North Carolina and BA from the University of California at Berkeley.

John Molyneux
Vice President of Manufacturing Operations

Mr. Molyneux brings with him over 20 years of high tech and medical device experience including manufacturing engineering and operations management in the UK, Canada and the United States. Most recently, Mr. Molyneux was Site Manager for Integra Lifesciences in San Diego, where he was responsible for manufacturing operations for disposable intercranial pressure monitoring catheters. Prior to joining Integra, he was Director of Manufacturing at Sequenom, responsible for manufacturing operations for genetic testing consumables. Previous to Sequenom, he worked with i-STAT Canada (now Abbott Point-of-Care) and semiconductor manufacturers, LSI Logic in Canada, and Plessey Semiconductors in the UK. Mr Molyneux holds a BSC in Physical Electronics from Bradford University.

Maria Pizarro, PMP
Vice President of Research and Development

Ms. Pizarro brings over 20 years of industry experience developing and manufacturing high technology products as well as medical devices. Her early career experience involved working at various aerospace companies: Hughes Aircraft (Raytheon), TRW, Loral-Librascope, and Eaton Corporation. Ms. Pizarro spent 10 years at Boston Scientific, Neurovascular Division, where she led neurovascular minimally invasive device research (intracranial implantable devices) and development projects from concept to commercialization. Prior to joining TMI, Ms. Pizarro was the Director of Research and Development at AngioScore Inc., where she led the development of cardiovascular and peripheral devices. A certified project manager, Ms. Pizarro obtained her Bachelor of Science degree from Texas A&M University and continued her post-graduate studies at UCLA.

Shiva Ardakani
Vice President of of Regulatory Affairs, Quality Assurance and Clinical Affairs

Ms. Ardakani brings with her 20 years of regulatory and quality experience in medical device startups and a solid track record in successful companies. Prior to joining TMI, Ms. Ardakani was Vice President of Regulatory, Quality and Clinical at Tenaxis, a company that produces vascular sealants for surgical hemostasis. Prior to Tenaxis, she held Director of Regulatory and Quality positions with EndoTex Interventional Systems and Advanced Stent Technologies (AST), both acquired by Boston Scientific. Ms. Ardakani was responsible for obtaining ISO Certification and CE marking for AST, EndoTex, and Tenaxis products. Previously, she held key quality management positions at ORATEC Interventions (acquired by Smith & Nephew), Micrus Fidus Medical Technology, and Fusion Medical Technologies (acquired by Baxter). In addition, she was instrumental in developing and managing the Quality Engineering and Quality Control departments. Ms. Ardakani has been published in numerous medical journals, holds a BS in Physics from San Jose State University, and is currently a member of the Regulatory Affairs Professionals Society.